Company: CXAI
Filing Date: 2025-08-11
Form Type: S-3
Source: 0001829126-25-006018
Chunk: 43

Company: CXApp Inc.
Filing Date: 2025-08-11
Form: S-3
Chunk 43
---
 cause the trading price of our common stock to decline and you may lose all or part of your investment. The risks described below are not the only ones that we face. Additional risks not presently known to us or that we currently deem immaterial may also significantly impair our business operations and could result in a complete loss of your investment.

Risks Related to this Offering and to our Common Stock

Since we have broad discretion in how we use the proceeds from this offering, we may use the proceeds in ways with which you disagree.

We have not allocated specific amounts of the net proceeds from this offering for any specific purpose. Accordingly, our management will have flexibility in applying the net proceeds of this offering. You will be relying on the judgment of our management with regard to the use of these net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used appropriately. It is possible that the net proceeds will be invested in a way that does not yield a favorable, or any, return for us. The failure of our management to use such funds effectively could have a material adverse effect on our business, financial condition, operating results and cash flow.

Sales of a significant number of shares of our common stock in the public markets, or the perception that such sales could occur, could depress the market price of our common stock.

Sales of a substantial number of shares of our common stock in the public markets could depress the market price of our common stock and impair our ability to raise capital through the sale of additional equity securities. We cannot predict the effect that future sales of our common stock would have on the market price of our common stock.

You may experience immediate and substantial dilution in the book value per share of the common stock you purchase in the offering.

The shares sold in this offering,
if any, will be sold from time to time at various prices. The offering price per share in this offering may exceed the net tangible book
value per share of our common stock outstanding prior to this offering. For illustrative purposes, assuming that an aggregate of 8,592,291
shares of our common stock are sold at a price of $0.9263 per share, the last reported sale price of our common stock on Nasdaq on August
5, 2025, for aggregate gross proceeds of approximately $7,959,040, and after deducting commissions and estimated aggregate offering expenses
payable by us, you will experience immediate dilution of approximately $0.8373 per share,